Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients
NCT00586716
·
clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
22
Enrollment
OTHER
Sponsor class
Stopped
Insufficient recruitment
Conditions
End Stage Renal Disease
Interventions
DRUG:
intravenous immune globulin
Sponsor
Loma Linda University